List view / Grid view
More than 346 million people worldwide are living with diabetes, and the World Diabetes Foundation estimates that number will increase by nearly 27 percent by 2030. In order to help physicians appropriately monitor treatment efficacy for these patients, Abbott announced today CE Marking (Conformité Européenne) for the Abbott ARCHITECT HbA1c…
10 July 2012 | By Boehringer Ingelheim
Boehringer Ingelheim is concentrating on new business models...
10 July 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb announced on Friday, June 29, 2012, its intent to acquire Amylin...
Lonza, a world leader in gene expression and biopharmaceutical development of protein therapeutics, announced today the launch of the new GS Xceed™ Gene Expression System.
9 July 2012 | By European Medicines Agency (EMA)
The EMA has been notified by Sanofi-aventis of its decision to withdraw its marketing authorisation application for Mulsevo...
9 July 2012 | By B&W Tek
B&W Tek, Inc., is thrilled to introduce their exciting and intuitive new website...
9 July 2012 | By Phenomenex Inc
The SecurityGuard™ ULTRA UHPLC column protection system has been recognized as one of the top innovations of 2012...
9 July 2012 | By Boehringer Ingelheim
"We are very pleased to sponsor the joint research programs..."
6 July 2012 | By Abbott
Groundbreaking partnership that aims to speed the discovery of essential new treatments...
6 July 2012 | By Eli Lilly and Company
Eli Lilly and Company has met the United States FDA requirements for pediatric exclusivity for Cymbalta®...
6 July 2012 | By AstraZeneca
AstraZeneca has completed the previously indicated sale of the assets of its subsidiary, Aptium Oncology...
5 July 2012 | By Boehringer Ingelheim
Joachim Hasenmaier to lead new Board Division Consumer Healthcare and Animal Health...
5 July 2012 | By Amgen
Amgen has announced the completion of the acquisition of KAI Pharmaceuticals, a privately held company based in South San Francisco...
5 July 2012 | By Biogen Idec
Biogen Idec and SOBI announced the initiation of two global pediatric clinical trials...
4 July 2012 | By Sanofi
"We are pleased to have been able to support the development of the Yves Rocher Group for about 40 years...”
